EUVIMEDEUVIMED entdecken
Crossref

Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles

Umay Merve Güven, Murat Sami Berkman, Yasemin Yazan

ACTA Pharmaceutica Sciencia · 2019

DOI: 10.23893/1307-2080.aps.05701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACTA Pharmaceutica Sciencia, 2019. Verfasst von Umay Merve Güven und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The conventional eye drops are the most convenient and patient compliant non-invasive route for topical ophthalmic drug delivery. Nasolachrymal drainage, epithelial membrane barriers and non-productive absorption of these ophthalmic preparations can result in poor ocular bioavailability and systemic absorption leading side effects. The limited duration time requires frequently dosing up to 4 times per day for many treatments 1. The active ingredient can ABSTRACT

Zitieren

APA

Güven, U. M., Berkman, M. S., & Yazan, Y. (2019). Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles. ACTA Pharmaceutica Sciencia. https://doi.org/10.23893/1307-2080.aps.05701

Vancouver

Güven UM, Berkman MS, Yazan Y. Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles. ACTA Pharmaceutica Sciencia. 2019. doi:10.23893/1307-2080.aps.05701

BibTeX
@article{Gven2019,
  author = {Güven, Umay Merve and Berkman, Murat Sami and Yazan, Yasemin},
  title = {Development and validation of uplc method for the determination of olopatadine hydrochloride in polymeric nanoparticles},
  journal = {ACTA Pharmaceutica Sciencia},
  year = {2019},
  doi = {10.23893/1307-2080.aps.05701}
}
Kostenlos starten →